Rank by score ***(p < 0.001) | Inhibitor ID | Ranking score | # selections | avg score per selection | avg score per participants |
1st | o1 | 377 | 51 | 7.39 | 4.24 |
2nd | o5 | 309 | 46 | 6.72 | 3.47 |
3rd | o7 | 231 | 37 | 6.24 | 2.60 |
4th | o4 | 191 | 30 | 6.37 | 2.15 |
5th | o6 | 184 | 31 | 5.94 | 2.07 |
6th | o2 | 149 | 22 | 6.77 | 1.67 |
7th | o3 | 140 | 23 | 6.09 | 1.57 |
8th | oNA | 56 | 7 | 8.00 | 0.63 |
Rank by score ***(p < 0.001) | Inhibitor ID | Ranking score | # selections | avg score per selection | avg score per participants |
1st | b1 | 265 | 38 | 6.97 | 2.98 |
2nd | b5 | 261 | 39 | 6.69 | 2.93 |
3rd | b3 | 224 | 32 | 7.00 | 2.52 |
4th | b4 | 219 | 32 | 6.84 | 2.46 |
5th | b2 | 213 | 31 | 6.87 | 2.39 |
6th | b7 | 146 | 24 | 6.08 | 1.64 |
7th | b6 | 138 | 22 | 6.27 | 1.55 |
8th | bNA | 64 | 8 | 8.00 | 0.72 |
Rank by score ***(p < 0.001) | Inhibitor ID | Ranking score | # selections | avg score per selection | avg score per participants |
1st | t3 | 385 | 40 | 9.63 | 4.33 |
2nd | t2 | 351 | 35 | 10.03 | 3.94 |
3rd | t1 | 320 | 32 | 10.00 | 3.60 |
4th | t9 | 261 | 30 | 8.70 | 2.93 |
5th | t4 | 248 | 26 | 9.54 | 2.79 |
6th | t7 | 212 | 24 | 8.83 | 2.38 |
7th | t6 | 200 | 22 | 9.09 | 2.25 |
8th | tNA | 99 | 9 | 11.00 | 1.11 |
9th | t8 | 98 | 12 | 8.17 | 1.10 |
10th | t10 | 96 | 12 | 8.00 | 1.08 |
11th | t5 | 83 | 11 | 7.55 | 0.93 |
Rank by score ***(p < 0.001) | Inhibitor ID | Ranking score | # selections | avg score per selection | avg score per participants |
1st | i1 | 230 | 41 | 5.61 | 2.58 |
2nd | i2 | 175 | 34 | 5.15 | 1.97 |
3rd | i5 | 159 | 31 | 5.13 | 1.79 |
4th | i4 | 129 | 25 | 5.16 | 1.45 |
5th | iNA | 90 | 15 | 6.00 | 1.01 |
6th | i3 | 74 | 16 | 4.63 | 0.83 |